|
|||||
|
|

Technology distribution company ScanSource (NASDAQ:SCSC) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 4.6% year on year to $739.7 million. On the other hand, the company’s full-year revenue guidance of $3.2 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.06 per share was 14% above analysts’ consensus estimates.
Is now the time to buy SCSC? Find out in our full research report (it’s free for active Edge members).
ScanSource’s third quarter results were met with a negative market reaction, as sales came in below Wall Street expectations and declined year over year. Management attributed the underperformance largely to continued weakness in Brazil and the effects of reporting more netted down revenue, particularly in the company’s Specialty Technology Solutions segment. CEO Mike Baur acknowledged that while some technology categories grew in North America, certain legacy areas remained in decline, tempering overall top-line momentum. Baur highlighted ongoing gross profit margin improvements and growth in recurring revenue, stating, “Each of our segments achieved year-over-year gross profit growth and higher EBITDA margins.”
Looking ahead, ScanSource’s management sees opportunities for profitable growth driven by acquisitions and a shift toward higher-margin, recurring revenue businesses. CEO Mike Baur explained that the company’s four business presidents are now directly responsible for pursuing both organic and inorganic opportunities in their markets, with a renewed emphasis on strategic M&A and channel programs for emerging tech suppliers. CFO Steve Jones cautioned that while the company is confident in its full-year outlook, the timing of large deals and the evolving mix between traditional and newer revenue streams could still introduce variability in quarterly performance. Management believes that investments in AI education, channel expansion, and acquisition integration will underpin future growth.
Management pointed to several factors shaping Q3 performance, including segment-level weakness in Brazil, a favorable shift in gross profit mix, and the initial benefits from recent acquisitions.
ScanSource’s outlook is shaped by expanding its acquisition pipeline, continued growth in recurring revenue streams, and strategic investments in emerging channel technologies.
Looking ahead, the StockStory team will be watching (1) the pace and integration of new acquisitions in emerging, high-margin segments, (2) the continued growth in recurring revenue streams from advisory and AI-enabled services, and (3) stabilization or improvement in Brazil’s demand environment. Execution of the Integrated Solutions Group’s new business development initiatives and onboarding innovative suppliers will also be important markers for sustained profitability and growth.
ScanSource currently trades at $40.37, down from $41.83 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free for active Edge members).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Nov-07 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-05 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Oct-31 | |
| Oct-29 | |
| Oct-21 | |
| Oct-20 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite